The CEO letter already came out last Thursday, 13th July.
The next report are the Quarterly Cash flow and Activity, which will tell us all about the sales, BARDA reimbursement, receipts etc. There is nothing to be exciting about, unless they will be lodging the FDA submission between now and 28th July or they will trigger the BARDA procurement.
Still no mention of any contracts signed in the world wide markets. I assume they are still in trial stage, which will be very disappointing.
CEO Shareholder Letter and Quarterly Report, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.80 |
Change
-0.030(1.06%) |
Mkt cap ! $197.1M | |||
| Open | High | Low | Value | Volume |
| $2.83 | $2.89 | $2.80 | $299.8K | 105.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3700 | $2.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.83 | 10724 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| AVH (ASX) Chart |